KoreaMed Synapse

Journal List > Korean J Gastroenterol > v.62(5) > 1007166

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Ko: Is Infantile Inflammatory Bowel Disease Curable with Hematopoietic Stem Cell Transplantation?

Research Update

Korean J Gastroenterol 2013;62(5):313-314.

Published online: 4 October 2013

DOI: https://doi.org/10.4166/kjg.2013.62.5.313

Is Infantile Inflammatory Bowel Disease Curable with Hematopoietic Stem Cell Transplantation?

Jae Sung Ko

Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea

Correspondence to: Jae Sung Ko, Department of Pediatrics, Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea. Tel: +82-2-2072-2197, Fax: +82-2-743-3455, E-mail: kojs@snu.ac.kr

Copyright © 2013 Korean Ophthalmological Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Article

Loss of Interleukin-10 Signaling and Infantile Inflammatory Bowel Disease: Implications for Diagnosis and Therapy

References

1. Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012; 143:347–355.

2. Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009; 361:2033–2045.

3. Glocker EO, Frede N, Perro M, et al. Infant colitis–it's in the genes. Lancet. 2010; 376:1272.

4. Begue B, Verdier J, Rieux-Laucat F, et al. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol. 2011; 106:1544–1555.

5. Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013; 131:825–830.

6. Mao H, Yang W, Lee PP, et al. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neo-natal-onset Crohn's disease. Genes Immun. 2012; 13:437–442.

7. Shim JO, Hwang S, Yang HR, et al. Interleukin-10 receptor mutations in children with neonatal-onset Crohn's disease and intractable ulcerating enterocolitis. Eur J Gastroenterol Hepatol. 2013; 25:1235–1240.

8. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleu-kin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75:263–274.

9. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40:1319–1323.

10. Amre DK, Mack DR, Morgan K, et al. Interleukin 10 (IL-10) gene variants and susceptibility for paediatric onset Crohn's disease. Aliment Pharmacol Ther. 2009; 29:1025–1031.

11. Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013; 19:115–123.

12. Denson LA. How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients? Curr Gastroenterol Rep. 2012; 14:275–281.

TOOLS

Similar articles